ECO Animal Health Group plc (AIM:EAH)

Market Cap	67.08M
Revenue (ttm)	85.81M
Net Income (ttm)	3.02M
Shares Out	67.76M
EPS (ttm)	0.04
PE Ratio	22.80
Forward PE	38.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	75,299
Average Volume	60,216
Open	100.60
Previous Close	103.50
Day's Range	98.15 - 103.00
52-Week Range	50.00 - 116.90
Beta	-0.01
RSI	46.20
Earnings Date	Mar 2, 2026

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infectio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 224
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EAH

Financial Performance

In 2024, ECO Animal Health Group's revenue was 79.60 million, a decrease of -10.99% compared to the previous year's 89.42 million. Earnings were 1.69 million, an increase of 60.88%.